A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
A field test of empathetic refutational and motivational interviewing to address vaccine hesitancy among patients
Tekijät: Fasce, Angelo; Mustata, Mirela; Deliu, Alexandra; Holford, Dawn; Karlsson, Linda; Gould, Virginia; Dumitra, Gheorghe Gindrovel; Farcasanu, Dana; Visinescu, Iulia; Verger, Pierre; Lewandowsky, Stephan
Kustantaja: NATURE PORTFOLIO
Kustannuspaikka: BERLIN
Julkaisuvuosi: 2025
Journal: NPJ VACCINES
Tietokannassa oleva lehden nimi: NPJ VACCINES
Lehden akronyymi: NPJ VACCINES
Artikkelin numero: 142
Vuosikerta: 10
Numero: 1
Sivujen määrä: 11
eISSN: 2059-0105
DOI: https://doi.org/10.1038/s41541-025-01197-8
Verkko-osoite: https://www.nature.com/articles/s41541-025-01197-8
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/499253302
Vaccine hesitancy is among the most concerning public health issues due to declining immunization rates worldwide. We report a mixed-methods field test of two conversational techniques that allow for an empathetic dialogue on vaccination between health care professionals and patients: Empathetic-refutational interviewing (ERI) and motivational interviewing (MI). Thirty Romanian general practitioners were assigned to an untrained control group and to two experimental groups in which they were trained in ERI or MI. After training, physicians had conversations on HPV and influenza vaccines with 334 patients who were hesitant to receive a vaccination. Patients of physicians in the ERI group demonstrated larger increases in positive attitudes toward vaccines and willingness to get vaccinated, while a greater proportion of patients in the MI group scheduled vaccination appointments. Interviews with participating physicians revealed overall satisfaction with the conversational techniques. Empathetic interpersonal communication can have a substantial positive impact on vaccination rates, especially for vaccines subject to mass misinformation campaigns.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
Julkaisussa olevat rahoitustiedot:
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 964728 (JITSUVAX). A.F. has received funding from the Alexander von Humboldt Foundation.
